Alkermes Plc Stock Price, News & Analysis
ALKS
NASDAQ
Company Description
Welcome to the overview page for Alkermes Plc (ALKS), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
$27.90
-2.07%
0.59
Last updated: December 29, 2025 at 10:38
-4.43 %
Performance 1 year
$4.7B
165.1M
Latest News
SEC Filings
Insider Radar
Net Sellers
90-Day Summary
0
Shares Bought
18,000
Shares Sold
2
Transactions
Most Recent Transaction
Hopkinson Craig C.
(EVP R&D, Chief Medical Officer)
sold
9,000 shares
@ $30.38
on Nov 3, 2025
Based on SEC Form 4 filings over the last 90 days.
Financial Highlights
$1,557,632,000
Revenue (TTM)
$367,070,000
Net Income (TTM)
$2.17
$439,124,000
Operating Cash Flow
23.57%
27.00%
Upcoming Events
JAN
01
January 1, 2026 - March 31, 2026
Clinical
Start global Phase 3 program
Initiation of global Phase 3 program for alixorexton
JAN
01
January 1, 2026 - March 31, 2026
Corporate
Acquisition close
Expected closing of Alkermes acquisition of Avadel, subject to regulatory and shareholder approvals
JAN
01
January 1, 2026 - March 31, 2026
Clinical
Global Phase 3 program start
Initiation of global Phase 3 program for alixorexton in NT1 patients
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of Alkermes Plc (ALKS)?
The current stock price of Alkermes Plc (ALKS) is $28.49 as of December 26, 2025.
What is the market cap of Alkermes Plc (ALKS)?
The market cap of Alkermes Plc (ALKS) is approximately 4.7B. Learn more about what market capitalization means .
What is the revenue (TTM) of Alkermes Plc (ALKS) stock?
The trailing twelve months (TTM) revenue of Alkermes Plc (ALKS) is $1,557,632,000.
What is the net income of Alkermes Plc (ALKS)?
The trailing twelve months (TTM) net income of Alkermes Plc (ALKS) is $367,070,000.
What is the earnings per share (EPS) of Alkermes Plc (ALKS)?
The diluted earnings per share (EPS) of Alkermes Plc (ALKS) is $2.17 on a trailing twelve months (TTM) basis. Learn more about EPS .
What is the operating cash flow of Alkermes Plc (ALKS)?
The operating cash flow of Alkermes Plc (ALKS) is $439,124,000. Learn about cash flow.
What is the profit margin of Alkermes Plc (ALKS)?
The net profit margin of Alkermes Plc (ALKS) is 23.57%. Learn about profit margins.
What is the operating margin of Alkermes Plc (ALKS)?
The operating profit margin of Alkermes Plc (ALKS) is 27.00%. Learn about operating margins.
What is the gross margin of Alkermes Plc (ALKS)?
The gross profit margin of Alkermes Plc (ALKS) is 84.25%. Learn about gross margins.
What is the current ratio of Alkermes Plc (ALKS)?
The current ratio of Alkermes Plc (ALKS) is 3.04, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.
What is the gross profit of Alkermes Plc (ALKS)?
The gross profit of Alkermes Plc (ALKS) is $1,312,301,000 on a trailing twelve months (TTM) basis.
What is the operating income of Alkermes Plc (ALKS)?
The operating income of Alkermes Plc (ALKS) is $420,636,000. Learn about operating income.